• SRAX sells remaining MD ownership stake for $8 million
• MD sale allows SRAX to focus on rapid growth of Sequire platform
• Sequire unlocks big data investor insights for public companies
• Sequire revenue grew 29% year-over-year for Q2 2020, user base doubled to one million users during Q3 2020

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS platform, has recently sold its remaining stake in its MD healthcare vertical for $8 million.

SRAX’s final divestment in MD represents the latest in a series of strategic moves that are further solidifying SRAX’s position in the investment industry. Along with spinning off its proprietary data-based BIGtoken platform into its own private company, SRAX has also acquired LD Micro, a leading data and event company serving the small and micro-cap space that provides exclusive information on micro-cap North American stocks.

“Our Sequire platform is rapidly growing and we are focused on the continued expansion of this business,” said SRAX founder and CEO Christopher Miglino (https://ibn.fm/0vwNh). “We believe that selling the MD ownership stake at this time reinforces our goal of being 100% focused on providing our platform and services to public companies. This capital will be effective in helping us accelerate growth. This asset currently sits on our balance sheet with a zero basis, so this capital will go directly to improving our balance sheet. This transaction combined with moving Bigtoken to its own public company brings clarity to our mission going forward.”

Sequire’s suite of tools allows public companies to unlock the power of investor data through warrant tracking, survey creation, events and roadshows, and customer relationship/resource management (“CRM”). Since its creation in 2019, the platform has grown rapidly, doubling its user base to over one million investors and traders across 91 public companies in just two months (https://ibn.fm/wv6L7) in addition to posting Q2 earnings that showed a 29% increase in year-over-year revenue. The acquisition of LD Micro is expected to further accelerate the adoption of Sequire, paving a new road forward for both companies.

“The platform is an absolute game-changer for public companies and their shareholders,” said LD Micro founder Chris Lahiji in recent statements (https://ibn.fm/ACfcV). “Both companies believe that one day executives will rely on Sequire the same way investors rely on Bloomberg.”

SRAX is on the Russell Microcap(R) Index in addition to being invited to the board of the Interactive Advertising Bureau (“IAB”) Data Policy Board. Through the creation of specialized tools that reveal core consumers and their characteristics, SRAX continues to leverage the growing demand for quantifiable and detailed consumer data across a wide range of industries.

For more information, visit the company’s website at www.SRAX.com.

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX

• SGMD releases key numbers for BudCars Q3 2020 financial report
• CEO reports that company “continues to perform, setting records in basically every key metric we track”
• BudCars has seen consistent growth since Sugarmade acquired 40% stake in the Sacramento-based cannabis delivery service

Steadily growing gross margins, more than 60% growth and $2 million in gross receipts are a few of the highlights in an announcement (https://ibn.fm/8gnHK) made by Sugarmade (OTCQB: SGMD) featuring the Q3 2020 numbers for BudCars Cannabis Delivery Service. SGMD owns a 40% stake in BudCars, along with an option to acquire an additional 30%.

“BudCars continues to perform, setting records in basically every key metric we track,” said Sugarmade CEO Jimmy Chan. “It was a tremendous quarter, with a big jump in customers and regional market share and robust margins on every sale. That paints a very motivating picture as we gear up to significantly expand our service territory, with upcoming expansion into the North Bay and Wine Country areas, as well as our upcoming grand opening of BudCars LA.”

The preannouncement of BudCars’ performance for the three months ended Sept. 30, 2020, included the following key numbers:

• Total Q3 2020 BudCars gross receipts over $1.9 million, which represents a 66% increase quarter over quarter
• Total Q3 BudCars gross profits of $903,667, representing 64% gross profit growth quarter over quarter on a steady 47% gross profit margins
• Average daily gross sales increased $21,246, a 68% increase quarter to quarter
• Total customer tickets increased 62% quarter to quarter on 3% growth in average ticket size

BudCars has seen consistent growth since Sugarmade acquired a 40% stake in the Sacramento-based cannabis delivery service earlier this year (https://ibn.fm/jjr74). In fact, the company has performed ahead of expectations almost every month since March 2020, seeing consistent growth in almost every area, including increasing new customers, strong repeat business, increasing orders per customer per period, and increasing ticket sizes.

BudCars isn’t the only bright spot on the Sugarmade horizon. The company also recently secured rights to a property zoned for cannabis cultivation (https://ibn.fm/ps9IP). The company is already in the process of obtaining cannabis cultivation licensing, preparing archaeological and biological surveys, and assembling documentation related to the architectural and engineering plans for construction of greenhouses and a processing building.

“We believe we have all of the strategic pieces in place to capitalize on cultivation, with the market currently chronically undersupplied,” said Chan. “We also have relationships in place, especially through our BudCars investment, to hit the ground running on the branded products side, driving strong margins up and down the chain.”

BudCars is a retail business that offers same-day delivery of top-quality cannabis. Customers choose from a variety of products including edibles, flower, pre-rolls, vapes, tinctures and concentrate across dozens of premium brands. Once consumers complete their purchases online, they receive their order the same day via BudCars Cannabis Delivery Service.

Sugarmade is a product and branding marketing company investing in operations and technologies with disruptive potential. The company’s brand portfolio includes CarryOutsupplies.com, SugarRush(TM) and Budcars.com. Sugarmade is an investor in BudCars and a joint operator of BudCars’ first operating location in Sacramento, California.

During early 2020, Sugarmade gained a 40% stake in BudCars and in the Sacramento delivery operations via the acquisition of a 40% stake in Indigo Dye Group (Indigo). Under the terms of Sugarmade’s agreement with Indigo, Sugarmade also acquired an option to purchase an additional 30% interest in Indigo, upon the closing of which would provide Sugarmade with a 70% controlling interest. As of the date hereof, this option has not yet been exercised; Sugarmade’s stake in Indigo remains at 40%, and there is no assurance that Sugarmade will exercise the option to acquire an additional 30% interest in Indigo.

However, since late May 2020, Sugarmade has been actively involved in development of Indigo’s operations with power to direct the activities and significantly impact Indigo’s economic performance. Sugarmade also has obligations to absorb losses and right to receive benefits from Indigo. As such, in accordance with the Financial Accounting Standards Board’s Accounting Standards Codification 810-10-25-38A through 25-38J, Indigo is considered a variable interest entity (“VIE”) of Sugarmade.

For more information, visit the company’s website at www.Sugarmade.com.

NOTE TO INVESTORS:: The latest news and updates relating to SGMD are available in the company’s newsroom at http://ibn.fm/SUGAR

• Plant-based superfood developer Rritual Mushrooms Inc. has produced its initial product lineup of three functional mushroom elixirs and powders designed to boost personal wellness
• The company was recognized by retail marketing agency ECRM for its attractive product presentation and growing success, as judged by national outlets including CVS, Vitamin Shoppe, Amazon and Rite Aid
• The functional mushroom market is a nascent subsection of the wellness industry ripe with potential for companies that get in on the ground floor as expectations for the industry grow
• Rritual’s Reishi Relax, Chaga Immune and Lion’s Mane Focus formulations are available in 14-stick packs and in 250-gram tubs, as well as in a 14-day variety pack that includes all three elixirs

Lifestyle therapeutics innovator Rritual Mushrooms gained recognition for its development of attractive marketing and its growing market presence at the 2020 annual ECRM Buyer’s Choice Awards.

The awards spotlight Efficient Collaborative Retail Marketing, and Rritual Mushrooms achieved second place in the Whole Body & Mind Wellness category, which was voted on by wellness product buyers from national retail outlets in a virtual event last month (https://ibn.fm/xEIAx).

“Rritual’s performance at the ECRM Buyer’s Choice Awards was not only a vote of confidence for the long-term potential of our product line but also a clear indication that there is strong demand for high-quality and accessible mushroom products among mainstream consumers and retailers alike,” Rritual’s CEO David Kerbel stated.

Rritual Mushroom is a premium brand in the functional mushroom market, an industry that is still in its infancy and ripe with potential for early movers. Certain mushrooms have long been touted for their beneficial properties — as an example, the Reishi mushroom enjoys a reputation as “the mushroom of immortality” after thousands of years of use in traditional Chinese medicine for boosting the immune system, fighting off cancer, fatigue and depression, supporting heart health, and helping to control blood sugar levels (https://ibn.fm/T5mVn).

Rritual has introduced an initial product line of elixirs, shots and mixes for three mushroom varieties paired with select adaptogens — herbal substances used to increase the body’s ability to resist biological stress (https://ibn.fm/JzamN). In addition to Reishi, which is paired with the adaptogen Ashwagandha root, Rritual’s products pair the Chaga mushroom with Eleuthero root and the Lion’s Mane mushroom with Rhodiola root.

“I believe Rritual has a great business model and product portfolio, in addition to a talented and passionate management team that uniquely positions it for success in the emerging plant-based industry,” Dr. Mike Hart, the company’s new president stated when he was hired in June (https://ibn.fm/rQY5o). “Their mission to help people adapt to modern life and prove that mushrooms are one of the world’s greatest superfoods is a perfect fit with my own wellness practices as a physician, and personally as an individual who is passionate about mental and physical health.”

Each Reishi Relax, Chaga Immune and Lion’s Mane Focus elixir also contains a blend of six functional mushrooms including turkey tail, shiitake and maitake, as well as a prebiotic blend featuring inulin and lucuma fruit powder, which together are designed to support immune and digestive health.

ECRM VP of Health and Beauty Care Craig Chmielowicz noted the timeliness of Rritual’s product offering, stating, “A big part of wellness these days — especially during the pandemic — includes finding ways to relax the body and mind” (https://ibn.fm/tO6y8).

For more information, visit the company’s website at https://Investors.WeAreRritual.com.

“Mental Fitness is a Daily Ritual”

NOTE TO INVESTORS: The latest news and updates relating to Rritual Mushrooms are available in the company’s newsroom at http://ibn.fm/Rritual

• Majority of game developers surveyed believe that eSports industry will continue to grow in coming years
• eSports attracts the largest audience on the planet at more than 600 million people
• Colleges, universities and high schools now offering eSports as academic classes with opportunities for scholarships

Mobius Interactive is an online gaming operator featuring various unique offerings catering to diverse demographic groups. In partnership with Ultra Play, a leading and award-winning eSports and iGaming platform, the company seeks to attract a network of high net-worth gamers from around the world.

Mobius.Bet is the company’s dedicated eSports hub catering to the growing eSports segment. By the end of 2021, the sector will reach 2.7 billion gamers playing worldwide, according to Mobius CEO Lynn Pearce, in a recent “Infinity Gaming” article (https://ibn.fm/7b0Y8).

Pearce isn’t the only one forecasting growth in the space. Perforce, an American developer of software used for developing and running applications, recently surveyed game development professionals and found that the majority believe that the eSports industry will only continue to grow in the coming year (https://ibn.fm/AaCQP). This is in part due to the impact of COVID-19. As individuals look for more ways to stay connected and entertained, eSports will only continue to grow.

Earlier this year, “The Manual” reported that eSports attracts the largest audience on the planet at over 600 million people (https://ibn.fm/rqP1c). At the beginning of the pandemic, it was one of the few remaining social activities and live-entertainment options available. According to the “LA Times,” eSports was built for quarantine culture and had eight million people logging on daily (https://ibn.fm/zHqFI).

However, the popularity of eSports was actually growing before the world was forced to stay home and find new avenues of entertainment. Well before COVID-19, more than 170 colleges and universities were participating in eSports. High schools have created eSports classes, not categorized as sports but as an academic class. College scholarships, tournament money and high salary jobs are now possibilities in the space. Gaming is no longer solitary. It has become a social activity that pushes players to their best, develops skills, and requires teamwork and strategy (https://ibn.fm/gn8aV).

One of the main challenges pointed out by Pearce and those surveyed by Perforce is funding. Monetizing eSports is not an easy endeavor. Part of the challenge is the speed of sports and the thrill of betting in the fast-paced arena. eSports is slower, with games, competitions and tournaments lasting longer. Fans, especially those placing bets, want instant action.

Or they did. With COVID-19 slowing down lives and shifting attention from what was once the norm, there is a new interest and patience in the eSports arena. And that interest is accompanied by funding.

As an online gaming operator featuring a variety of unique offerings catering to diverse demographic groups, Mobius Interactive is well positioned to leverage the growing interest as smart money is increasingly betting on esports. The company is partnering with award-winning eSports and iGaming platform Ultra Play and more than 600 VIP and master-gaming affiliates seeking to attract high-net-worth gamers worldwide. Led by management with experience in eSports and handling the launches of more 30 successful products within the last three years, Mobius Interactive is set out to become a notable player in this growing sector.

To learn more about this company, visit www.MobiusInteractive.Ltd.

NOTE TO INVESTORS: The latest news and updates relating to Mobius are available in the company’s newsroom at http://ibn.fm/Mobius

• New research reports that almost half of music fans want virtual concerts to continue
• FDBL’s Fan Pass platform just offered first-ever livestream Halloween concert
• Company’s vision already beginning to redefine artist-fan relationship

Livestreaming concerts are a creative byproduct of the global pandemic, a modern-day solution to the heartbreaking cancellation of live performances and concerts. A new Music 360 report by MRC Data, however, suggests that almost half of music fans want virtual concerts to continue, even after COVID-19 restrictions are eased (https://ibn.fm/CUjyX). That’s music to the ears of Friendable (OTC: FDBL), which just wrapped its first-ever livestreaming Halloween concert, which featured artists S-mack (x2), Mamd, R.T.A and Ball Hog Beats.

“The livestream business has become a necessity since the start of the pandemic,” reported a recent “EDMTunes” article, titled “Half of Music Fans Want Virtual Concerts to Stay” (https://ibn.fm/GgXyI). “Its current prevalent importance has left a positive impact on the industry. This is why virtual concerts are likely to stick around once venues and concert halls resume operations.”

Friendable, a mobile technology and marketing company focused on connecting and engaging users through its proprietary mobile and desktop applications, is banking on that being the case. Earlier this year, the company launched its flagship product, the Fan Pass app. Fan Pass is a livestreaming platform that supports artists at all levels, providing exclusive artist-content channels, livestreaming events, promotional support, fan subscriptions and custom merchandise designs, all of which serve as revenue streams for each artist. The recent Fan Pass Halloween event featured artists who recently approved their artist channels on the Fan Pass platform and now have the ability to schedule, promote and hold virtual events (https://ibn.fm/HbNfF).

“We, along with our friends, family and staff, enjoyed viewing each one of these performances,” said Friendable CEO Robert A. Rositano Jr. “Even more enjoyable was the excitement expressed in discussions centering on all Fan Pass has to offer, and we envision a bright future for the platform and our brand.

“In total, the events generated over 15,933 impressions by approximately 124 users, as well as attracting more than 545 fan interactions with artist content, which continues to show traction and display how our model works,” Rositano continued. “We believe our vision is already beginning to redefine the artist-fan relationship as we push forward to support each artist at every level and work to simultaneously uncover new revenue opportunities for them. Thank you to all our performers, their fans and our shareholders for your support.”

The Halloween event, the first of several holiday-themed livestream events planned for the upcoming season, lasted more than three hours and is available for fans to view via the Fan Pass app or the Fan Pass website using the “Live on Demand” playback feature.

Friendable’s Fan Pass app, artists can offer exclusive content channels to their fans, who simply use their smartphones to gain access to their favorite artists as well as an all-access pass, giving them access to all artists on the platform. Additionally, the Fan Pass team will deploy social broadcasters to capture exclusive VIP experiences, interviews and behind-the-scenes content featuring their favorite artists — all available to fan subscribers for free on a trial basis. Following the trial, subscriptions are billed monthly at $3.99, or about the cost of downloading a couple of songs, providing VIP access at a fraction of the cost of traditional face-to-face meetups.

For more information about Friendable or the Fan Pass platform, services and offering, visit the company’s website at www.Friendable.com or www.FanPassLive.com.

NOTE TO INVESTORS: The latest news and updates relating to FDBL are available in the company’s newsroom at http://ibn.fm/FDBL

• POAI subsidiary Soluble Biotech’s optimization solution shaves time and cost off of traditional options offered by competition
• Results garnered from company’s HSC optimization are unparalleled in field
• Soluble Biotech lands first major contract, signifying major company milestone

Offering a proprietary automated High Throughput Self-Interaction Chromatography(TM) (“HSC”) Technology Platform, Predictive Oncology (NASDAQ: POAI) provides biomedical and pharmaceutical companies with superior options never before available. A knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, POAI, through its subsidiary Soluble Biotech, delivers a solution that reduces the cost, time and manpower needed to optimize therapeutic formulations.

HSC Technology is a self-contained, automated system that conducts high-throughput, self-interaction chromatography screens, using additives and excipients commonly included in protein formulations (https://ibn.fm/vbZ53). The data generated from these screens is analyzed by a predictive algorithm used to identify the optimal combination of additives and excipients, resulting in increased solubility and physical stability of proteins. And while the technology produces unparalleled optimization results, it provides other benefits as well.

Using current methods, optimization can take more than a year, cost hundreds of thousands of dollars and require teams of five or more individuals to complete. Optimization with HSC, on the other hand, takes only three months, costs tens of thousands of dollars, and needs just one individual to conduct. The comparison is stark — and irresistible. Soluble Biotech has already finalized its first substantial contract since being acquired by POAI earlier this year and is currently negotiating additional contracts (https://ibn.fm/rZyMr).

“Our first contract is a major milestone and validates our recent move into a new, larger facility,” said Soluble Biotech founder Dr. Larry DeLucas, who is also a former NASA astronaut. “We quadrupled our laboratory and office space, some of which will eventually include a GMP facility. Additionally, we acquired state-of-the-art equipment to support our fermentation, therapeutic protein formulation development and protein stability studies.”

A provider of soluble and stable formulations for proteins including vaccines, antibodies, large and small proteins and protein complexes, Soluble Biotech is fast becoming recognized for its expertise in enhancing the drug-development process by rapidly optimizing protein solubility and stability. The company brings proprietary transformational technology to formulation development for protein-based pharmaceuticals and vaccines. In addition, its solubilization and stability technology is used at academic, pharmaceutical and government laboratories involved in conducting fundamental protein research.

Soluble Biotech’s exclusive HSC technology was developed by Dr. William Wilson, a former chairman of the chemistry department at Mississippi State University, and DeLucas; the two have spent almost 20 years developing the game-changing technology and tool. HSC has been validated over the past decade through numerous industry and academic collaborations with several clients seeing tenfold and even hundredfold increases in their protein’s solubility while also maintaining physical stability. For the pharmaceutical sector, this means faster development times and quicker progression of molecules into the clinic. In academics, these results lead to further progression of biochemical and biology studies that are vital to advance fundamental research in areas of unmet medical need.

Predictive Oncology operates through three segments (domestic, international and other), which contain four subsidiaries: Helomics, TumorGenesis, Skyline Medical and Soluble Biotech. Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. TumorGenesis Inc. specializes in media that help cancer cells grow and retain their DNA/RNA and proteomic signatures, providing researchers with a tool to expand and study cancer cell types found in tumors of the blood and organ systems of all mammals, including humans. Skyline Medical markets its patented and FDA cleared STREAMWAY System, which automates the collection, measurement and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions. Soluble Biotech is a provider of soluble and stable formulations for proteins including vaccines, antibodies, large and small proteins and protein complexes.

For more information, visit the company’s website at www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

• National Storm Recovery Inc. acquired Mulch Manufacturing Inc. several months ago to create SGTM
• SGTM diverts storm waste from landfills to create attractive next-generation products that benefit the environment
• Mulch Manufacturing recently secured many new contracts that include The Kroger Co., Circle K, Menards Inc. and Old Castle Lawn & Garden
• SGTM’s Q2 results nearly doubled from previous quarter; include $12.3 million revenue, $3.4 million gross profit

Proving the theory that the whole is greater than the sum of its parts, National Storm Recovery Inc. recently acquired Mulch Manufacturing Inc. to create the Sustainable Green Team (OTC: SGTM) – a leading provider of environmentally-beneficial solutions for tree and storm waste disposal. Besides increased sales, greater profits and international expansion, the synergistic activities of both companies further solidify their shared roles as stewards of the environment through the creation of organic products that benefit nature while diverting natural waste from landfills.

“With Mulch Manufacturing’s national and international distribution, its sales contracts with many big box retailers, and the increase in production and packaging capacity it provides, this strategic acquisition has positioned us as The Sustainable Green Team,” said SGTM CEO Tony Raynor at the time of the acquisition (https://ibn.fm/ct1we).

SGTM primarily provides solutions for the treatment and handling of tree debris created by storms that typically gets sent to disposal sites. Along with creating additional pressure on landfills, this natural waste further increases municipal expenses while contributing to the overall environmental burden experienced across the nation. With over 40 years of combined next-level experience, SGTM provides services that convert this problem into profits by collecting, treating and caring for these trees and transforming them into products that include garden mulch and playground surfacing material.

Besides making good economic sense, the move continues to pay dividends in the form of increased profits – despite the economic recession connected to COVID-19. SGTM just keeps on growing, and part of that growth is attributed to contracts between Mulch Manufacturing and large industry players like The Kroger Co., Circle K, Menards Inc., Old Castle Lawn & Garden, and many more.

“This business combination has created an industry power house; and with our combined strengths, puts us in an ideal position to increase our sales and resulting margins, as our combined operations benefit from the resulting vertical integration and economies of scale,” noted Mulch Manufacturing CEO Ralph Spencer.

Management forecasts at the time of the acquisition have materialized with better results than expected. SGTM’s profits nearly doubled in a quarter, leading to impressive Q2 results that include $12.3 million in revenue and $3.4 million in gross profit (https://ibn.fm/ySmKU). Along with the increased contracts from Mulch Manufacturing, much of this growth can also be attributed to relief efforts in the wake of Hurricane Laura along with new contracts between SGTM’s strategic partners and state municipalities.

STGM’s strong commitment to environmental sustainability served as a primary motivation behind the name and ticker change from National Storm Recovery Inc. (OTC: NSRI) to Sustainable Green Team, Ltd. (OTC: SGTM). Along with driving forward its environmental mission, the company is also committed to maximizing shareholder value, particularly for investors looking to leverage profitable – and ethical – opportunities during times of economic uncertainty.

To learn more about Sustainable Green Team Ltd., view the investor presentation at https://ibn.fm/OSR73.

NOTE TO INVESTORS: The latest news and updates relating to SGTM are available in the company’s newsroom at http://ibn.fm/SGTM

• Knightscope is a leader in the development of autonomous security capabilities and is on target to disrupt the $500 billion security industry
• The company is presently in the process of raising up to $25 million in additional growth capital as it prepares for a possible public listing
• With more than 16,000 investors, over $70 million raised since inception and several Fortune 1000 clients with prepaid contracts, Knightscope is poised to be an industry leader in the future of public safety and security
• The company has opened investing to the public through its latest Reg A+ offering at $10 per share
• This innovation has the potential to drive cost savings and profitability for clients; manufacturing costs can be recovered as soon as the first year of operation
• The company’s ASRs have assisted in the arrest of suspects involved in crimes ranging from armed robbery to hit-and-runs; the machines’ embedded thermal scanning capabilities also aided in preventing the breakout of a major fire

Knightscope Inc., founded in 2013 and based in Mountain View, California, is a leader in the development of autonomous security capabilities on target to disrupt the $500 billion security industry. Knightscope’s technology uniquely combines self-driving technology, robotics and artificial intelligence.

Knightscope designs and builds Autonomous Security Robots (“ASRs”) that provide 24/7/365 security to the places you live, work, visit and study. The company’s client list covers public institutions and commercial business operations, including multiple Fortune 1000 companies to date. These ASRs have been proven to enhance safety at hospitals, logistics facilities, manufacturing plants, schools and corporations. ASRs act as highly cost-effective complementary systems to traditional security and law enforcement officials, providing an additional advantage by continuing to offer uninterrupted patrolling capabilities across the country, despite the pandemic (note: robots are immune).

The company’s ASRs have assisted in the arrest of suspects involved in crimes ranging from armed robbery to hit-and-runs. Their machine-embedded thermal scanning capability even aided in preventing the breakout of a major fire. You can learn more about the crime fighting wins at www.Knightscope.com/Crime

The company has achieved several milestones since its creation in 2013, including:

• Establishing itself in a 15,000-square-foot facility located in Mountain View, California, in the heart of Silicon Valley, where Knightscope designs, engineers and builds its technology;
• Operating for more than one million hours in the field and securing contracts across five time zones;
• Navigating through the global pandemic without interruption by continuing to operate on a daily basis across the nation and supporting clients classified as essential services; and
• Continuing its hiring processes despite the current societal and economic disruption.

Growth Capital

With backing from more than 16,000 investors and four major corporations and over $70 million raised since inception, Knightscope is poised to be an industry leader in the future of public safety and security.

The company is presently in the process of raising up to an additional $25 million in growth capital as it prepares for a potential public listing. Knightscope has reserved ticker symbol ‘KSCP’ with Nasdaq.

Investors can buy shares exclusively through the company’s managing broker-dealer, StartEngine.

Knightscope’s latest Reg A+ offering is for up to 2.5 million shares of Series S preferred stock convertible into shares of Class A common stock at a price to the public of $10 per share.

Company Mission – Reimagining Public Safety

Knightscope’s long-term vision has an eye on the greater good. The company’s mission is to make the United States of America the safest nation in the world while supporting millions of law enforcement and security professionals across the country.

Crime has a negative economic impact in excess of $1 trillion annually. As crime is reduced, positive impacts will likely be realized across several aspects of society, including housing, financial markets, insurance, municipal budgets, local business and safety in general.

Knightscope CEO William Santana Li was recently interviewed by Kevin O’Leary, more commonly known as Shark Tank’s Mr. Wonderful. When asked to explain how the benefits provided by the ASRs outrank a human doing the same job, Li said, “First, just the simple presence of a physical deterrent causes criminal behavior to change. Second, the machines are self-driving cars that patrol all around and recharge themselves. They also generate 90 terabytes of data per year. No human would ever be able to process that. The robots are intended to be eyes and ears for the humans, not a one to one replacement.”

The Knightscope solution to reduce crime combines the physical presence of ASRs, sometimes referred to as proprietary Autonomous Data Machines, with real-time onsite data collection and analysis. The ASRs are fitted with eye-level 360° cameras, thermal scanning, public address announcements and various other features that work in tandem with humans to provide law enforcement officers and security guards unprecedented situational awareness.

Those 90 terabytes of data are then formatted in a useable way, so law enforcement can leverage that information and execute their responsibilities more effectively.

Public Safety Innovation

The company’s recurring revenue business model is set up to mimic the recurring societal problem of crime, and it takes into consideration the fact that innovation in the security and public safety industry has been stagnant for decades. Because the traditional practices of the sector have remained unchanged for years, automation has potential to drive substantial cost savings – and significant improvement in capabilities.

Human security guards are one of both the largest expenses and the largest liabilities for companies. Knightscope’s robots are offered at an effective price of $4 to $11 per hour, compared with approximately $85 and $30 per hour for an armed off duty law enforcement officer and an unarmed security guard, respectively.

This innovation has the potential to drive considerable cost savings. Based on these estimates, manufacturing costs can be recovered as soon as the first year of operation.

Product Offerings

The company has eight patents and a framework of unique intellectual property. Knightscope currently offers a K1 stationary machine, a K3 indoor machine and a K5 outdoor machine. A K7 multi-terrain four-wheel version is in development.

The ASRs autonomously patrol client sites without the need for remote control, providing a visible, force multiplying, physical security presence to help protect assets, monitor changes in the area and deter crime. The data is accessible through the Knightscope Security Operations Center (KSOC), an intuitive, browser-based interface that enables security professionals to review events generated by the ASRs providing effectively ‘mobile smart eyes and ears’.

The ASRs and all the related technologies were developed ground up by the Company and are Made in the USA.

Management Team

Chief Executive Officer William Santana Li is a veteran entrepreneur, a former executive at Ford Motor Company and the founder of GreenLeaf, a company that grew to be the world’s second-largest automotive recycler and is now part of LKQ Corporation (NASDAQ: LKQ).

Chief Client Officer Stacy Dean Stephens brings his experience as a former Dallas law enforcement officer, as well as his skills as a seasoned entrepreneur, to assist on the client acquisition side.

Chief Intelligence Officer Mercedes Soria is an award-winning technologist and former Deloitte software engineer.

Chief Design Officer Aaron Lehnhardt brings over two decades of two- and three-dimensional product and industrial design in modeling and VR to the table, on top of his experience as a senior designer at Ford Motor Company.

Chief Financial Officer Mallorie Burke is a seasoned financial executive and strategic advisor for both private and publicly traded technology companies with a successful track record of mergers & acquisitions, corporate growth and exit strategies, including public listings.

For more information, visit the company’s website at www.Knightscope.com

NOTE TO INVESTORS: The latest news and updates relating to Knightscope are available in the company’s newsroom at https://ibn.fm/Knight 

Episode 132 of the Wild West Crypto Show carries on its mission of preaching the value consumers can find in alternative currencies, even during seasons of social and financial unrest. Hosts Drew Taylor and Brent Bates pepper their podcast commentary about the state of the cryptocurrency industry with observations about business activity, U.S. politics and even evangelical prophecy, all with Texas-flavored humor undergirding their interviews.

The episode, titled, “Cryptos Always Run When We Interview Bo!” refers to the pair’s interview with Biblical cycle and financial analyst Bo Polny, who uses his insights on market timing to anchor the final portion of the 50-minute show.

Along the way, Taylor and Bates also speak with Adrian Crion, the founder and CEO of Germany-based Spielworks, an onboarding company dedicated to bringing users, specifically mass-market gamers, onto blockchain. And Chris Davis, the CTO of Film.Io, talks about his platform for getting unknown filmmakers on a level playing field with more established industry insiders by helping them build a mass-market audience America’s Got Talent-style, so that when they are prepared to make a pitch to studios or financial backers they can show that they’ve already built significant audience interest.

CryptoCurrencyWire Communications Director Jonathan Keim is a show regular, offering additional insights on crypto space news headlines from around the world. In this episode, Keim acknowledges new signs that alternatives to the dollar are gaining mainstream recognition.

When Cointelegraph reported that U.S. Currency Comptroller Brian Brooks stated that decentralized finance movements will spawn “inevitable” change and will render many of the services banks provide obsolete, “just as email disrupted the postal service,” Keim called it a sign that “everybody is waking up” to a fact that he and the show’s hosts have previously discussed many times.

“It’s just exciting when you hear people like Brian Brooks say these kinds of things. We’re seeing so much movement in this past year. It’s really insane. And not just here in the U.S. but abroad as well,” Keim added.

Keim also noted that the chairman of the U.S. Federal Reserve has said its financial institutions aren’t in a hurry to introduce central bank digital currency, which prompted Morgan Creek Digital co-founder Anthony Pompliano to argue that time is of the essence and if it doesn’t act “the U.S. is going to fall really far behind China because it all comes down to accessibility.”

“In our small town, we have a bank and a chicken place on every corner and a convenience store across the street. We’ve got plenty of all that sort of stuff,” Bates quipped. “The U.S. getting involved in this is going to help all those unbanked people and is going to help all these other economies by being able to provide liquidity and everything that the U.S. dollar and digital dollar could bring.”

Bates expressed excitement at news that crypto gaming pioneer Cloudbet is adding Pax Gold coin to its platform to make betting with gold backing possible in a first for the gaming world.

“You can’t carry all your gold with you. It becomes heavy and kind of hard to lug around,” Bates said. “You take that little thumb drive around with you, it could have a billion dollars or it could have 59 cents and everything in between. It’s so much more pragmatic for it to be digitized and to carry around a piece of it.”

Keim said what he finds so interesting is that there are so many alternatives to the dollar “springing up all over the place” as means for currency transactions.

“This world-first accomplishment is only feasible because a gold-backed crypto is easily divisible and easier to exchange,” he said.

The Wild West Crypto Show podcast appears online and in multiple markets across the country. Bates’ and Taylor’s purpose is to educate people about alt-currencies “so that they’re not afraid of it.”

To view the latest episode, which includes CryptoCurrencyWire’s ongoing segment featuring recent news from around the world, visit hhttps://ibn.fm/3wzvf.

• VistaGen has three innovative CNS drug candidates which target a wide range of anxiety, depression and neurological disorders
• PH94B, the Company’s most advanced drug candidate, is entering Phase 3 development for acute, on-demand treatment of social anxiety disorder
• Company sees potential to displace benzodiazepines currently being used to treat multiple anxiety disorders
• Strategy has gained in importance after U.S. FDA announced in late-September its update requirement for boxed warnings on all benzodiazepines to highlight risks of abuse, misuse, addiction, and physical dependence
• Benzodiazepine epidemic is as worrisome as the opioid epidemic – 92 million benzodiazepine prescriptions in 2019 according to the FDA

VistaGen Therapeutics (NASDAQ: VTGN) is a biopharmaceutical company committed to developing a new generation of medications which go beyond the standard of care for anxiety, depression, and several neurological disorders. The company’s product portfolio consists of three novel drug candidates which seek to target a wide variety of central nervous system (“CNS”) disorders through medications with potential to not only be effective but also present fewer side-effects and safety concerns relative to the current standard of care. Its initiative relating to anxiety disorders has unique potential to pay dividends following recent actions taken by the U.S. Food and Drug Administration (“FDA”) involving benzodiazepines, a class of drugs widely used to treat anxiety disorders, as well as insomnia and seizures.

In late September 2020, the FDA announced that it would require the boxed warning on all benzodiazepines to be updated to describe the risks of abuse, misuse, addiction, physical dependence and withdrawal reactions consistent to all medicines in this class (https://ibn.fm/sHdvF).

A review carried out by the FDA found that benzodiazepines were widely prescribed in the U.S., with 92 million prescriptions in 2019, often for extended periods of time. The study also found that benzodiazepines were widely abused and misused, often together with alcohol, prescription opioids, and illicit drugs—all of which could result in serious issues. Separately, the FDA study also revealed that some patients were found to have suffered serious withdrawal reactions after benzodiazepines were stopped suddenly or the dose reduced quickly, with a significant minority experiencing difficult withdrawal symptoms for several months.

With its lead drug candidate, PH94B, entering Phase 3 development in 2021, VistaGen Therapeutics is focused on displacing benzodiazepines in the treatment paradigm for the acute treatment of social anxiety disorder, as well as many other anxiety disorders.

The global CNS therapeutics market is estimated to reach $130 billion by 2025 and has been forecast to grow at a CAGR of more than 5.93% between 2018-2025. A rise in mental illnesses and increased awareness of psychiatric disorders (https://ibn.fm/I0JiR), conditions which have been exacerbated during the COVID-19 pandemic, have been calculated to cost the global economy an estimated $1 trillion each year. The impact of these conditions is particularly devastating among the young. Industry data suggest that approximately 20% of the world’s children and teens are affected by mental health conditions, and suicide is the leading cause of death among 15- to 29-year-olds (https://ibn.fm/53t2R).

The impact of mental health disorders on patient lives and the wider global economy, coupled with the potential risks associated to conventional benzodiazepine drugs, have increased the urgent need for pharmaceutical companies to develop more effective and safer alternatives to the current standard of care available to patients today. As such, VistaGen has taken it upon itself to help address the millions of underserved patients suffering from anxiety and depression disorders whose current treatments are either inadequate or generate debilitating side effects and serious safety concerns, including risk of abuse and death.

“Now more than ever, the new generation anti-anxiety and antidepressant medications we are developing at VistaGen – PH94B, PH10 and AV-101 – are relevant, necessary and demand the highly-focused and passionate efforts of our team and partners, with the support of our stockholders, to advance them to patients whose lives are disrupted by anxiety and depression disorders,” VistaGen CEO and Director Shawn K. Singh said in his closing remarks at the company’s 2020 Annual Meeting of stockholders (https://ibn.fm/UyTmK).

For more information, visit the company’s website at www.VistaGen.com.

NOTE TO INVESTORS: The latest news and updates relating to VTGN are available in the company’s newsroom at https://ibn.fm/VTGN